| Wal-mart Pharmacy 10-1633 | |
| 21 County Road 120, Saint Cloud, Minnesota 56303 | |
| (320) 259-6363 |
| Name | Wal-mart Pharmacy 10-1633 |
|---|---|
| Organization Name | Walmart Inc |
| Location | 21 County Road 120, Saint Cloud, Minnesota 56303 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (320) 259-6363 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Gliomas arise from the supporting cells of the brain, called the glia. These cells are subdivided into astrocytes, ependymal cells and oligodendroglial cells (or oligos). These tumors are graded from the lowest grade 1 to highest grade 4, with glioblastoma multiforme being the highest grade and deadliest type of glioma.
AEterna Zentaris Inc. today reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for urology, cetrorelix pamoate. As announced on March 6, 2009, sanofi-aventis U.S. LLC entered into an agreement with AEterna Zentaris for the development, registration and marketing of cetrorelix in BPH for the U.S. market.
Many heart disease patients who are already receiving state-of-the-art therapy do not benefit from additional treatment with angiotensin converting enzyme (ACE) inhibitors, according to results of a new study funded by the National Heart, Lung, and Blood Institute (NHLBI).
Provista, LLC announced today that it has partnered with Administered Risk Management Services Rx, LLC (ARMSRx), a pharmacy benefit consulting firm that specializes in delivering superior results and ongoing support to the administration and management of prescription drug benefit programs and afford Provista members with the highest-quality pharmaceutical care at the lowest possible cost.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 8 days ago
| NPI Number | 1265459630 |
| Organization Name | WALMART INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 21 County Rd, St Cloud, MN 56301 |
| Phone Number | 320-259-6363 |
News Archive
Gliomas arise from the supporting cells of the brain, called the glia. These cells are subdivided into astrocytes, ependymal cells and oligodendroglial cells (or oligos). These tumors are graded from the lowest grade 1 to highest grade 4, with glioblastoma multiforme being the highest grade and deadliest type of glioma.
AEterna Zentaris Inc. today reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for urology, cetrorelix pamoate. As announced on March 6, 2009, sanofi-aventis U.S. LLC entered into an agreement with AEterna Zentaris for the development, registration and marketing of cetrorelix in BPH for the U.S. market.
Many heart disease patients who are already receiving state-of-the-art therapy do not benefit from additional treatment with angiotensin converting enzyme (ACE) inhibitors, according to results of a new study funded by the National Heart, Lung, and Blood Institute (NHLBI).
Provista, LLC announced today that it has partnered with Administered Risk Management Services Rx, LLC (ARMSRx), a pharmacy benefit consulting firm that specializes in delivering superior results and ongoing support to the administration and management of prescription drug benefit programs and afford Provista members with the highest-quality pharmaceutical care at the lowest possible cost.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 8 days ago
News Archive
Gliomas arise from the supporting cells of the brain, called the glia. These cells are subdivided into astrocytes, ependymal cells and oligodendroglial cells (or oligos). These tumors are graded from the lowest grade 1 to highest grade 4, with glioblastoma multiforme being the highest grade and deadliest type of glioma.
AEterna Zentaris Inc. today reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for urology, cetrorelix pamoate. As announced on March 6, 2009, sanofi-aventis U.S. LLC entered into an agreement with AEterna Zentaris for the development, registration and marketing of cetrorelix in BPH for the U.S. market.
Many heart disease patients who are already receiving state-of-the-art therapy do not benefit from additional treatment with angiotensin converting enzyme (ACE) inhibitors, according to results of a new study funded by the National Heart, Lung, and Blood Institute (NHLBI).
Provista, LLC announced today that it has partnered with Administered Risk Management Services Rx, LLC (ARMSRx), a pharmacy benefit consulting firm that specializes in delivering superior results and ongoing support to the administration and management of prescription drug benefit programs and afford Provista members with the highest-quality pharmaceutical care at the lowest possible cost.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 8 days ago
Centracare Clinic Type: Medicare Supplier Location: 1200 6th Ave N, Saint Cloud, Minnesota 56303 Phone: (320) 252-5131 | |
Cvs Pharmacy #16352 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 125 Lincoln Ave Se, Saint Cloud, Minnesota 56304 Phone: (320) 654-0712 | |
Cvs Pharmacy #16054 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4201 W Division St, Suite A124, Saint Cloud, Minnesota 56301 Phone: (320) 253-4646 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3900 Roosevelt Rd, Saint Cloud, Minnesota 56301 Phone: (320) 654-1747 | |
Wal-mart Pharmacy 10-1633 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 21 County Road 120, Saint Cloud, Minnesota 56303 Phone: (320) 259-6363 |